See All News - tctmd.com

News

News Daily News

CV Risk Factors in Youth May Prove Indelible for Later CAD

Marcus A. Banks

July 17, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Conference News SCCT 2019

CTA or Function Tests in High-risk Chest Pain and No Known CAD: Debate Goes On

Yael L. Maxwell

July 16, 2019

News Daily News

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Shelley Wood

July 16, 2019

News Daily News

Large, US Study Supports Single High-Sensitivity Troponin I Test for Suspected Acute MI

Todd Neale

July 16, 2019

News Industry News

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

July 16, 2019

News Industry News

Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

July 15, 2019

News Industry News

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

July 15, 2019

News Industry News

Abbott Receives U.S. Approval Of Next-Generation Mitraclip™, Bringing New Enhancements To Abbott's Leading Mitraclip Platform

July 15, 2019

News Daily News

Race, Wealth, and Neighborhood Predict Bystander CPR in Children

Marcus A. Banks

July 16, 2019

Advertisement

News

CV Risk Factors in Youth May Prove Indelible for Later CAD

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

CTA or Function Tests in High-risk Chest Pain and No Known CAD: Debate Goes On

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Large, US Study Supports Single High-Sensitivity Troponin I Test for Suspected Acute MI

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

Abbott Receives U.S. Approval Of Next-Generation Mitraclip™, Bringing New Enhancements To Abbott's Leading Mitraclip Platform

Race, Wealth, and Neighborhood Predict Bystander CPR in Children

Search News

Advertisement

Advertisement

News

Search News

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content